A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
NCT00073372 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 808
Last updated 2011-05-17
Summary
The purpose of this study is to determine the effectiveness of abciximab in the treatment of acute ischemic stroke.
Conditions
- Cerebrovascular Accident
- Brain Ischemia
- Acute Disease
Interventions
- DRUG
-
Abciximab
Sponsors & Collaborators
- collaborator INDUSTRY
-
Centocor, Inc.
lead INDUSTRY
Principal Investigators
-
Centocor, Inc. Clinical Trial · Centocor, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-10-31
- Completion
- 2005-12-31
More Related Trials
-
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke
NCT04309474 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
NCT02730455 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
Albumin in Acute Ischemic Stroke Trial
NCT00235495 ·Status: TERMINATED ·Phase: PHASE3
-
AXIS 2: AX200 for the Treatment of Ischemic Stroke
NCT00927836 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
NCT03290560 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment With AX200 for Acute Ischemic Stroke
NCT00132470 ·Status: COMPLETED ·Phase: PHASE2
-
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
NCT02818868 ·Status: COMPLETED
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
NCT05745311 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke
NCT05484154 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety Evaluation of 3K3A-APC in Ischemic Stroke
NCT02222714 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
NCT00061022 ·Status: COMPLETED ·Phase: PHASE3
-
Asia Africa Streptokinase Trial
NCT02150785 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prescriptive Infusion Algorithm (PIA)
NCT07215403 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pilot Investigation of Stem Cells in Stroke
NCT01151124 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT06755944 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study
NCT02640222 ·Status: COMPLETED
-
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
NCT02016547 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
NCT00894803 ·Status: COMPLETED ·Phase: PHASE2
-
Apixaban for Treatment of Embolic Stroke of Undetermined Source
NCT02427126 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
NCT02258880 ·Status: WITHDRAWN ·Phase: PHASE2